Robert E. Gagnon sold $127K of IRD stock

Robert E. Gagnon, Chief Financial Officer of Opus Genetics, Inc. (IRD), sold 28,000 shares of IRD stock worth $127K, per an SEC Form 4 filed Sep 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 3, 2026, 5 days before it was made public.

IRD has moved -9.1% since the trade date, from $4.60 to $4.18 (Nov 6, 2026 close).